
    
      After the prescreening, volunteers will be randomized into Group I or Group II. Each group
      will contain 16 volunteers. At least 5 volunteers in each group must be women. At month 0 all
      volunteers will receive multivalent HIV-1 peptide immunogen or the placebo. Group I will
      receive the injection in the deltoid and Group II will receive it in the anterior thigh. At
      months 1, 2 and 8 all patients will receive microparticulate monovalent HIV-1 peptide or the
      placebo. Follow up will be conducted.
    
  